Healthcare provider profile · identity verified

Corey Sullivan, MD

Family Practice · OLYMPIA, WA · NPI 1699110601

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	510	153
Amlodipine Besylate	Amlodipine Besylate	288	89
Lisinopril	Lisinopril	285	82
Levothyroxine Sodium	Levothyroxine Sodium	251	66
Losartan Potassium	Losartan Potassium	213	60
Omeprazole	Omeprazole	171	50
Metoprolol Succinate	Metoprolol Succinate	167	53
Tamsulosin Hcl	Tamsulosin Hcl	161	49
Metformin Hcl Er	Metformin Hcl	124	34
Gabapentin	Gabapentin	123	36
Trazodone Hcl	Trazodone Hcl	107	27
Jardiance	Empagliflozin	106	32
Rosuvastatin Calcium	Rosuvastatin Calcium	106	40
Albuterol Sulfate Hfa	Albuterol Sulfate	105	34
Hydrochlorothiazide	Hydrochlorothiazide	100	36
Metformin Hcl	Metformin Hcl	93	28
Sertraline Hcl	Sertraline Hcl	90	17
Eliquis	Apixaban	88	23
Mounjaro	Tirzepatide	78	14
Carvedilol	Carvedilol	70	22
Furosemide	Furosemide	58	21
Potassium Chloride	Potassium Chloride	58	19
Allopurinol	Allopurinol	57	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	11
Quetiapine Fumarate	Quetiapine Fumarate	53	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	19
Metoprolol Tartrate	Metoprolol Tartrate	49	17
Lorazepam	Lorazepam	47	11
Atenolol	Atenolol	46	13
Simvastatin	Simvastatin	46	16
Alprazolam	Alprazolam	45	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	44	11
Duloxetine Hcl	Duloxetine Hcl	43	12
Famotidine	Famotidine	39	11
Hydroxyzine Hcl	Hydroxyzine Hcl	39	12
Alendronate Sodium	Alendronate Sodium	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	11
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	17
Ozempic	Semaglutide	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	13
Pravastatin Sodium	Pravastatin Sodium	35	11
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Spironolactone	Spironolactone	34	11
Ipratropium Bromide	Ipratropium Bromide	33	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	19
Diazepam	Diazepam	31	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Pregabalin	Pregabalin	29	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Ondansetron Odt	Ondansetron	25	12
Acyclovir	Acyclovir	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Finasteride	Finasteride	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Naproxen	Naproxen	19	suppressed
Prednisone	Prednisone	19	13
Repatha Sureclick	Evolocumab	19	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Nortrel	Norethindrone-Ethin. Estradiol	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Estradiol	Estradiol	16	suppressed
Nitroglycerin	Nitroglycerin	16	12
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Glipizide	Glipizide	13	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Topiramate	Topiramate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error